SG Americas Securities’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $405K | Buy |
|
|||||
|
2025
Q2 | $154K | Sell |
|
|||||
|
2025
Q1 | $419K | Sell |
|
|||||
|
2024
Q4 | $374K | Sell |
|
|||||
|
2024
Q3 | $380K | Buy |
|
|||||
|
2024
Q2 | $368K | Buy |
|
|||||
|
2024
Q1 | $106K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $670K | Buy |
|
|||||
|
2023
Q2 | $636K | Buy |
|
|||||
|
2023
Q1 | $433K | Buy |
|
|||||
|
2022
Q4 | $102K | Sell |
|
|||||
|
2022
Q3 | $487K | Sell |
|
|||||
|
2022
Q2 | $952K | Buy |
|
|||||
|
2022
Q1 | $919K | Sell |
|
|||||
|
2021
Q4 | $1.65M | Buy |
|
|||||
|
2021
Q3 | $505K | Buy |
|
|||||
|
2021
Q2 | $369K | Sell |
|
|||||
|
2021
Q1 | $1.26M | Sell |
|
|||||
|
2020
Q4 | $3.87M | Buy |
|
|||||
|
2020
Q3 | $2.03M | Buy |
|
|||||
|
2020
Q2 | $148K | Sell |
|
|||||
|
2020
Q1 | $294K | Buy |
|
|||||
|
2019
Q4 | $234K | Sell |
|
|||||
|
2019
Q3 | $279K | Sell |
|
|||||
|
2019
Q2 | $3.69M | Buy |
|
|||||
|
2019
Q1 | $116K | Buy |
|
|||||
|
2018
Q4 | $108K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $396K | Buy |
|
|||||
|
2017
Q2 | $305K | Buy |
|
|||||
|
2017
Q1 | $124K | Sell |
|
|||||
|
2016
Q4 | $523K | Buy |
|
|||||
|
2016
Q3 | $254K | Sell |
|
|||||
|
2016
Q2 | $287K | Buy |
|
|||||
|
2016
Q1 | $192K | Buy |
|
|||||
|
2015
Q4 | $111K | Sell |
|
|||||
|
2015
Q3 | $405K | Buy |
|
|||||
|
2015
Q2 | $150K | Buy |
|
|||||
|
2015
Q1 | $167K | Sell |
|
|||||
|
2014
Q4 | $770K | Buy |
|
|||||
|
2014
Q3 | $417K | Buy |
|
|||||
|
2014
Q2 | $155K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $255K | Buy |
|